BACKGROUND: E-cigarettes (e-cigs) have attained widespread popularity, yet knowledge of their physiologic effects remains minimal. The aim of this study was to evaluate the effect of a single exposure to e-cig vapor on cough reflex sensitivity.
e-Cigarettes (e-cigs) have rapidly attained common usage worldwide, prompting significant discussion and speculation in the medical and lay media regarding potential harms and benefits of these devices, [1] [2] [3] [4] [5] [6] their role as smoking cessation aids, [7] [8] [9] [10] and how their sale and distribution should be regulated, if at all. 11, 12 Despite the popularity of e-cigs, remarkably little scientific data have been generated exploring the physiologic effects of e-cig use or "vaping." Few studies have evaluated the effect of e-cig use on the respiratory tract [13] [14] [15] [16] and on pulmonary function 17, 18 and none, to our knowledge, has evaluated its effect on cough reflex sensitivity. Indeed, there has been a call for increased medical research efforts in the field of health effects of e-cigs. 1, 19, 20 Previous studies have shown that otherwise healthy smokers of tobacco cigarettes have a diminished cough reflex sensitivity relative to nonsmokers, 21 presumably on the basis of chronic, cigarette smoke-induced desensitization of airway cough receptors. This hypothesis is supported by the demonstration, in chronic tobacco cigarette smokers, of enhancement of cough reflex sensitivity within 2 weeks of smoking cessation. 22 These studies suggest that cough reflex sensitivity is a dynamic phenomenon, able to be modulated by the presence or absence of stimuli such as cigarette smoke, even after prolonged exposure. 23 Thus, the aim of the present study was to evaluate the effect of a single exposure to e-cig vapor on cough reflex sensitivity in healthy nonsmokers.
e-cigs are electronic nicotine delivery devices. A cartridge within the e-cig contains nicotine in a vehicle of distilled water, as well as either vegetable glycerin or propylene glycol. A lithium battery within the e-cig generates heat, thus vaporizing the nicotine solution. No combustion is involved in the creation of the nicotinecontaining vapor that is inhaled by the user and promptly absorbed from the respiratory tract into the bloodstream. 24 Capsaicin, the pungent extract of red peppers, has been shown in over 3 decades of clinical experience to experimentally induce cough in a safe, dose-dependent, and reproducible manner. 25 Thus, capsaicin cough challenge testing has become an important tool in clinical research, allowing for the accurate measurement of the effect of a pharmacologic or other intervention on the sensitivity of the cough reflex. 25, 26 The standard end point measured in capsaicin cough challenge testing is the concentration of capsaicin inducing five or more coughs (C 5 ). In healthy volunteers, this end point has been demonstrated to be highly reproducible, in the short-term (20 min to 14 days) and long-term (months to years). 27 Standard capsaicin challenge methodology was used in this study to assess the effect of e-cig vapor exposure on cough reflex sensitivity.
Materials and Methods

Subjects
Thirty adult lifetime nonsmokers were enrolled after providing written, informed consent for this study, which was approved by the institutional review board of the Albert Einstein College of Medicine (institutional review board No. 2014-3288). Subjects were without history of asthma, gastroesophageal reflux disease, or symptoms suggestive of acute viral upper respiratory tract infection (common cold) or allergies within 4 weeks of enrollment. Subjects were not receiving medication known to affect cough reflex sensitivity.
Study Design
Upon enrollment, subjects underwent capsaicin challenge testing on day 1 to establish their baseline cough reflex sensitivity. On study day 2, subjects underwent an e-cig vaping session. Thus, 30 puffs of the e-cig delivered approximately 1.5 to 1.8 mg of nicotine. In comparison, the estimated nicotine intake from a tobacco cigarette is in the range of 1.07 to 2.6 mg, depending on the brand. 29, 30 Fifteen minutes after the conclusion of the e-cig session, subjects underwent capsaicin cough challenge. On study day 3, approximately 24 h after the vaping session, subjects underwent repeat capsaicin challenge. In addition, the number of coughs induced by each of the 30 puffs of the e-cig was tabulated. A cough number of five was assigned for at least five coughs.
A subgroup of eight subjects who demonstrated large degrees of cough reflex sensitivity inhibition after e-cig exposure (defined as at least a two doubling-concentration increase in C 5 ) underwent a repeat protocol identical to the above but with a disposable non-nicotinecontaining e-cig with similar vehicle (Full Tobacco flavor; Blue Star). Subjects were unaware that the e-cig used in this portion of the study was nicotine free.
Capsaicin Cough Challenge
Capsaicin cough challenge testing was performed as previously described. 25, 27 Briefly, subjects inhaled single, vital-capacity breaths of ascending, doubling concentrations (range, 0.49-1,000 mM) of aerosolized capsaicin solution, administered via a compressed airdriven nebulizer controlled by a dosimeter, with 1-min intervals between inhalations, until five or more coughs resulted in the 15 s following an inhalation. Placebo saline breaths were randomly interspersed between capsaicin doses to increase challenge blindness. The end point of capsaicin challenge testing is C 5 .
Statistical Analysis
Cough reflex sensitivity (C 5 ) was analyzed using mixed-effects modeling, with subsequent post hoc analysis correcting for multiple comparisons using the Tukey-Kramer approach. Pre-e-cig and post-e-cig exposure differences in C 5 response and number of coughs between nicotine and non-nicotine-containing e-cigs were compared using the Wilcoxon signed-rank test. Statistical analyses were performed using SAS version 9.3 software (SAS Institute, Inc).
Results
Thirty subjects (15 women; age, 29.8 AE 4.5 years [SD]) were enrolled and completed the study. After e-cig exposure, cough reflex sensitivity was significantly diminished (ie, C 5 was significantly increased) compared with baseline. This effect was transient, as demonstrated by the enhancement of cough reflex sensitivity back to baseline levels 24 h after the e-cig exposure. Mean log C 5 at baseline was 0.50 AE 0.09 (SEM); 15 min after electronic cigarette exposure it was 0.79 AE 0.11; and 24 h subsequently it was 0.55 AE 0.10. Using mixed-effects modeling, with subsequent post hoc analysis correcting for multiple comparisons using the Tukey-Kramer approach, the difference between log C 5 at baseline and post-e-cig exposure was significant (difference in mean log C 5 , À0.29; 95% CI, À0.43 to À0.15; P < .0001) as was the difference between post-e-cig use and 24 h later (difference in mean log C 5 , 0.24; 95% CI, 0.10-0.38; P ¼ .0002) (Fig 1) . In terms of individual responses, 23 of 30 subjects demonstrated an inhibition of cough reflex sensitivity (increased C 5 ) after e-cig exposure; five subjects had no change, and two subjects had a one-doubling concentration decrease in C 5 .
Twenty-six of the 30 subjects coughed to some degree in response to inhalation of the 30 puffs of the e-cig. The median number of coughs for the study group was To further investigate the role of nicotine in our observations, we performed an additional exploratory analysis by repeating an identical protocol of cough reflex sensitivity measurement before and after exposure to a non-nicotine-containing disposable e-cig in a subgroup of subjects. All eight subjects who had demonstrated large degrees of inhibition of cough reflex sensitivity after exposure to the nicotine-containing e-cig, defined as an at least two doubling-concentration increase in C 5 , agreed to participate in a follow-up study of a different brand of e-cig. Subjects were not aware that the e-cig being evaluated in the second phase of the study did not contain nicotine.
No inhibition of cough reflex sensitivity was observed after exposure to the non-nicotine-containing e-cig, in contrast to the change in C 5 after use of the nicotinecontaining e-cig (median difference in DC 5 , 0.6; range, 0.6-0.9; P ¼ .0078, Wilcoxon signed-rank test) (Fig 2) . In addition, significantly less coughing was observed after 30 puffs of the non-nicotine-containing e-cig compared with the nicotine-containing product (median difference in D number of coughs, six; range, 0-21; P ¼ .0156).
Discussion
We have demonstrated in a group of healthy adult nonsmokers that a single exposure to e-cig vapor, approximating the nicotine delivery of one tobacco cigarette, significantly inhibits cough reflex sensitivity as measured by capsaicin inhalation cough challenge testing. We noted the effect to be transient, as cough reflex sensitivity returned to baseline 24 h after e-cig use.
These findings are consistent with observations in healthy smokers of tobacco cigarettes, whose cough reflex sensitivity is suppressed relative to nonsmokers. 21 The demonstration that cough reflex sensitivity is journal.publications.chestnet.org significantly enhanced as soon as 2 weeks after smoking cessation supports the hypothesis that inhibition of cough reflex sensitivity is due to desensitization of cough receptors within the airway epithelium caused by chronic exposure to tobacco smoke. 22 Furthermore, as this effect is promptly reversible even after years of tobacco smoking, cough reflex sensitivity is apparently a dynamic phenomenon, able to be modulated by the presence or absence of stimuli such as tobacco smoke. 23 Given that these previous studies were performed in chronic tobacco cigarette smokers, the observations of the present study are perhaps more remarkable in that significant inhibition of cough reflex sensitivity was demonstrated after a single brief exposure to an e-cig. Our findings therefore raise the question of the effect on cough reflex sensitivity, and other pulmonary consequences, of repeated or chronic use of e-cigs and thus support the need for further investigation in this field. Indeed, if chronic e-cig use led to a sustained diminution of the cough reflex, one could speculate that loss of this important defense mechanism might have adverse clinical consequences. Furthermore, our demonstration of the acute effect of a single e-cig exposure on cough reflex sensitivity refutes the opinion of some that e-cig vapor is a benign and physiologically inert substance. A study demonstrating diminished cough reflex sensitivity in children exposed to environmental tobacco smoke relative to children not so exposed 31 supports the need for further investigation on potential secondhand effects of e-cigs. 6, 15 In an attempt to gain insight as to the causative agent within the e-cig vapor that led to significant inhibition of cough reflex sensitivity, we performed an exploratory analysis of a subgroup of our 30 subjects. Eight of the 30 subjects with the greatest degree of cough reflex suppression (defined as an elevation of capsaicin C 5 at least two doubling concentrations) after nicotinecontaining e-cig exposure were subsequently exposed in a similar manner to a non-nicotine-containing e-cig with similar flavoring and vehicle. The absence of an effect on cough reflex sensitivity implicates nicotine as the agent within the e-cig vapor causing the inhibition of cough reflex sensitivity that we observed. However, some degree of unintentional unblinding may have occurred in that the non-nicotine-containing e-cig vapor may have been perceived by subjects as qualitatively different from the nicotine-containing e-cig vapor, even though subjects were unaware that the second phase of the study used a non-nicotine-containing e-cig.
Several studies lend support to the hypothesis that nicotine is the main causative factor in our observations. In an in vivo model of e-cig exposure in mice, a chronic, 4-month exposure to nicotine-containing e-cig vapor caused airway hyperreactivity and emphysema, whereas the vehicle (50% propylene glycol/ 50% vegetable glycerin) had no effect. 32 Nicotine has been demonstrated in animals and humans to have a peripheral, rapid-onset, cough-inducing effect, probably through stimulation of nicotinic acetylcholine receptors expressed on sensory terminals of cough receptors within the airway mucosa 33 ; but in cats, nicotine has been shown to have an antitussive effect when administered centrally, suggesting that nicotinic acetylcholine receptors modulate brainstem functions, particularly caudal ventral respiratory column neurons involved in expression of the tracheobronchial cough reflex. 34 These observations may be relevant to the findings of the present study, since most of our subjects did cough immediately and transiently in response to e-cig inhalation, yet demonstrated inhibition of cough reflex sensitivity when measured 15 min after completion of the e-cig vaping session. In the subgroup of subjects who also underwent an exposure to a non-nicotine-containing e-cig, less cough occurred during the vaping session, and inhibition of cough reflex sensitivity was absent. Thus, the results of our study may be an illustration of a dual action of nicotine: an acute, peripheral tussive effect and a delayed, central antitussive effect. The putative action of nicotine as a centrally acting inhibitor of cough reflex sensitivity introduces the concept of nicotinic receptor agonists as potential therapeutic antitussive agents.
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